Related Experiment Video
Updated: Jul 17, 2026

Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
Published on: May 18, 2016
Human African trypanosomiasis of the CNS: current issues and challenges
1Department of Neurology, Division of Clinical Neurosciences, University of Glasgow, Institute of Neurological Sciences, Southern General Hospital, Glasgow, Scotland, United Kingdom. P.G.Kennedy@clinmed.gla.ac.uk
Abstract:
Human African trypanosomiasis (HAT), also known as sleeping sickness, is a major cause of mortality and morbidity in sub-Saharan Africa. Current therapy with melarsoprol for CNS HAT has unacceptable side-effects with an overall mortality of 5%. This review discusses the issues of diagnosis and staging of CNS disease, its neuropathogenesis, and the possibility of new therapies for treating late-stage disease.
More Related Videos
Related Concept Videos
Arboviral Encephalitis
Cryptococcal Meningitis
Malaria
Toxoplasmosis
American Trypanosomiasis
Antiprotozoal Agents

